Strategic partnership marks launch of early access program offering rapid, long, clonal gene synthesis and high-complexity genes up to 15 kb CORALVILLE, Iowa and SAN CARLOS Calif. — Global genomics solutions leader Integrated DNA Technologies (IDT) and Elegen, the leader in next-generation DNA manufacturing, are teaming up to offer IDT customers early access to Elegen’s ENFINIA™ Plasmid DNA, […]
Tokyo – Hitachi High-Tech Corporation (“Hitachi High-Tech”) is strengthening its analytical business through integrating and jointly operating its Hitachi High-Tech Analytical Science Ltd. (“Hitachi High-Tech Analytical Science”) and Hitachi High-Tech Science Corporation (“Hitachi High-Tech Science”) businesses. As of April 1, 2025, Hitachi High-Tech Science will become Hitachi High-Tech Analysis Corporation as part of this re-structure. By […]
FARMINGDALE, N.Y. — Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced its intention to voluntarily delist its common stock from The New York Stock Exchange (“NYSE”) and to have its common stock quoted on the OTCQX Best Market (“OTCQX”). Enzo provided notice of the voluntary delisting to the NYSE on March 28, […]
“This strategic partnership aligns with both companies’ missions to streamline genomic analysis by delivering cutting-edge solutions that accelerate discoveries and clinical decision-making. By leveraging Genomenon’s powerful datasets, Genomize users will gain access to deeper variant interpretation capabilities, driving innovation in personalized medicine.” Integration of Mastermind and Cancer Knowledgebase (CKB) Data To Drive Unprecedented Efficiency in […]
Espoo — Euformatics has signed a commercial contract with India-based genomics company Bencos Healthcare Solution Pvt Ltd to jointly develop clinical NGS bioinformatics solutions. This partnership aims at powering the large and fast-growing clinical genomics market in India. The scope of the collaboration covers the infusion of Euformatics tertiary analysis of NGS data with Bencos Healthcare […]
Building the world’s largest biobank with data from global populations to accelerate biomarker and drug discovery and development of next-generation diagnostics. Secured $25M in funding from F-Prime, Helios Digital Ventures, Digitalis Ventures, CEI Ventures, AME Cloud, Alexandria, Founders Collective, Stanford President’s Fund, and HBM Genomics. MIAMI — Galatea Bio, a leader in AI-driven genomic research […]
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Gregory J. Hayes to its board of directors, effective March 26, 2025. BD appoints Gregory J. Hayes to its board of directors. Hayes, 64, is currently the executive chairman of the board of […]
MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced Jim Gibson will join and be appointed as the company’s new Chief Financial Officer, effective as of his start date, which is expected to be March 31, 2025. With over three decades of financial leadership experience at some […]
COLOGNE, GERMANY – Singleron Biotechnologies today announced the launch of MobiuSCOPE, a single cell RNA sequencing kit that provides full-length transcript analysis using standard short-read sequencing. This solution captures alternative splicing events, gene fusions, and single nucleotide polymorphisms (SNPs) by providing complete transcript coverage and minimizing the 3′ or 5′ bias commonly found in conventional approaches. […]
License agreement provides Jumpcode Genomics access to CRISPR gene editing technology to enhance next-generation sequencing capabilities DUBLIN and SAN DIEGO — ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Jumpcode Genomics (‘Jumpcode’), a life science tools company improving and reducing the cost of next-generation sequencing technology, today announced a non-exclusive CRISPR/Cas9 license agreement. The agreement grants Jumpcode access […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
